Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
New agreement applies to the polymers of the Medical Care series portfolio
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
Specialty Chemicals grew 38% YoY for FY23
Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins
Subscribe To Our Newsletter & Stay Updated
